2022
Patient-centered trials in oncology: Time for a change
Med
•Research at a glance
Top areas of exploration
- Neoplasms , 8 publications
- Immune Checkpoint Inhibitors , 5 publications
- Immunotherapy , 5 publications
- Circulating Tumor DNA , 4 publications
Research activity
My publications
Filter publications
30 publications
2022
When Less May Be Enough: Dose Selection Strategies for Immune Checkpoint Inhibitors Focusing on AntiPD-(L)1 Agents
Targeted Oncology
•2021
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study
Journal for ImmunoTherapy of Cancer
•2021
Applications of Circulating Tumor DNA in a Cohort of Phase I Solid Tumor Patients Treated With Immunotherapy
JNCI Cancer Spectrum
•2021
Beyond immune checkpoint blockade: emerging immunological strategies
Nature Reviews Drug Discovery
•